Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review.

"Declarations Conflict of interestThe other authors have no financial or other conflicts of interest to disclose. Ethical approvalEthics approval was not required for this systematic review. Consent to participate/publishInformed consent was not required for this systematic review. Conflict of interest The other authors have no financial or other conflicts of interest to disclose."

"Funding Dr. Tree is supported by a Cancer Research UK Radiation Research Centre of Excellence at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust (grant ref: A28724) and a Cancer Research UK Programme Grant (ref: C33589/A28284). Dr. Tree acknowledges NHS funding to the NIHR Biomedical Research Centre at The Royal Marsden and The Institute of Cancer Research. The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care. Dr. Tree declares research funding from Elekta, Varian and Accuray. Dr Tree declares honoraria or travel assistance from Elekta, Accuray and Janssen. Dr. Seibert reports honoraria from Multimodal Imaging Services Corporation, Varian Medical Systems, and WebMD; has an equity interest in CorTech Labs, Inc, and serves on its scientific advisory board; and has received in-kind research support from GE Healthcare via a research agreement with the University of California, San Diego."